Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers [clinicaltrials:NCT01246791]

Bio2RDF identifier

NCT01246791

http://www.w3.org/2001/XMLSchema#string

Bio2RDF namespace

clinicaltrials

http://www.w3.org/2001/XMLSchema#string

Bio2RDF uri

http://bio2rdf.org/clinicaltrials:NCT01246791

http://www.w3.org/2001/XMLSchema#string

identifiers.org URI

NCT01246791

actual enrollment [clinicaltrials_vocabulary:actual-enrollment]

12

http://www.w3.org/2001/XMLSchema#integer

brief summary [clinicaltrials_vocabulary:brief-summary]

The purpose of this stu ...... max, t1/2, MRT, kel and AUC∞.

http://www.w3.org/2001/XMLSchema#string

brief title [clinicaltrials_vocabulary:brief-title]

Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

http://www.w3.org/2001/XMLSchema#string

clinical result [clinicaltrials_vocabulary:clinical-result]

clinical results for clinicaltrials:NCT01246791 [clinicaltrials_resource:17f1ccad2e2ee55cc32848930ca7b0e1]

clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:1f93baf723bd85e677a6b9601136245d]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:207b5fb97271907ac8d87379bc16b76b]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:64b09444cdd4bad8c5bf7d7d1f2700e5]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:76d7067ac5ecb2f2f30fe30103735613]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:80005f870768209e9b65f7b3e8ec3d92]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:9694fe9eea40b5f612f7f11f139e7463]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:aa1acd280469245b685e909d34173633]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:bb2681d100f518faab83e946d03c15f6]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:bcdbd9f8ed2eb46634c16768d8fd6d85]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 0, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 9.0, 12.0, 24.0 hours after single dosing of NPC-01 [clinicaltrials_resource:bd0ff4182909547be70a5876553f3b6e]

completion date [clinicaltrials_vocabulary:completion-date]

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

condition [clinicaltrials_vocabulary:condition]

Healthy [clinicaltrials_resource:396d45b57c2fbe3318e7b93272a2686b]

download date [clinicaltrials_vocabulary:download-date]

ClinicalTrials.gov processed this data on August 10, 2015

http://www.w3.org/2001/XMLSchema#string

eligibility [clinicaltrials_vocabulary:eligibility]

eligibility for clinicaltrials:NCT01246791 [clinicaltrials_resource:9a0bdd3caa4c5368dfe1ed9dc6a03a84]

firstreceived date [clinicaltrials_vocabulary:firstreceived-date]

2010-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

firstreceived results date [clinicaltrials_vocabulary:firstreceived-results-date]

2014-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

has expanded access [clinicaltrials_vocabulary:has-expanded-access]

No

http://www.w3.org/2001/XMLSchema#string

intervention [clinicaltrials_vocabulary:intervention]

NPC-01 [clinicaltrials_resource:5ccf2dbc8767936f43058d62589a414c]

intervention browse [clinicaltrials_vocabulary:intervention-browse]

Mestranol [clinicaltrials_resource:0166192da545e6d9717c8a4343ac3a50]

Norinyl [clinicaltrials_resource:1ff5ff260cfab7a0d5ace75c0de8534d]

Norethindrone acetate [clinicaltrials_resource:227df2d66006f73b328242c56b7863eb]

Estradiol 3-benzoate [clinicaltrials_resource:350b51592b9774b3f30685e19c911ecf]

Norethindrone [clinicaltrials_resource:5527f554d9ac440b8a90e5930c6f6bbb]

Polyestradiol phosphate [clinicaltrials_resource:6f84a00385bb3d23b3c7c62da0e7c3e6]

Ethinyl Estradiol [clinicaltrials_resource:8d8be834408fc83e7b63513fab54c6b0]

Estradiol 17 beta-cypionate [clinicaltrials_resource:91d0b0a56aceba5ea2ad10a738232593]

Estradiol [clinicaltrials_resource:a300cd65200686a5341ea728e79a7118]

Estradiol valerate [clinicaltrials_resource:d6938b287155c7009daa59f26186275b]

is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]

No

http://www.w3.org/2001/XMLSchema#string

keyword [clinicaltrials_vocabulary:keyword]

Ethinyl Estradiol

http://www.w3.org/2001/XMLSchema#string

Healthy female volunteer

http://www.w3.org/2001/XMLSchema#string

NPC-01

http://www.w3.org/2001/XMLSchema#string

Norethisterone

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics

http://www.w3.org/2001/XMLSchema#string

lastchanged date [clinicaltrials_vocabulary:lastchanged-date]

2014-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

lead sponsor [clinicaltrials_vocabulary:lead-sponsor]

Nobelpharma [clinicaltrials_resource:8ea02eeadbb7a673832c513c32215b7c]

nct id [clinicaltrials_vocabulary:nct-id]

NCT01246791

http://www.w3.org/2001/XMLSchema#string

number of arms [clinicaltrials_vocabulary:number-of-arms]

1

http://www.w3.org/2001/XMLSchema#integer

official title [clinicaltrials_vocabulary:official-title]

A Single Dose Pharmacokinetics ...... ) in Healthy Female Volunteers

http://www.w3.org/2001/XMLSchema#string

org study id [clinicaltrials_vocabulary:org-study-id]

NPC-01-3

http://www.w3.org/2001/XMLSchema#string

outcome [clinicaltrials_vocabulary:outcome]

Area Under the Plasma Concentration Versus Time Curve (AUC) on Norethisterone of NPC-01 [clinicaltrials_resource:NCT01246791/outcome/1]

overall official [clinicaltrials_vocabulary:overall-official]

Takefumi Matuo, MD [clinicaltrials_resource:30fc805f18995e00c3c512be2700565d]

overall status [clinicaltrials_vocabulary:overall-status]

Completed [clinicaltrials_resource:07ca5050e697392c9ed47e6453f1453f]

oversight [clinicaltrials_vocabulary:oversight]

Japan: Pharmaceuticals and Medical Devices Agency [clinicaltrials_resource:3466094b9b4632620642ee3720974c38]

participant flow [clinicaltrials_vocabulary:participant-flow]

participant flow for clinicaltrials:NCT01246791 [clinicaltrials_resource:31049187131ef31ad157430f6edba706]

phase [clinicaltrials_vocabulary:phase]

Phase 3 [clinicaltrials_resource:8357418e2694434468870b487644532d]

primary completion date [clinicaltrials_vocabulary:primary-completion-date]

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

reported events [clinicaltrials_vocabulary:reported-events]

Reported events for NCT01246791 [clinicaltrials_resource:cc2529ed523869e17d8b93c83733e987]

responsible party [clinicaltrials_vocabulary:responsible-party]

[clinicaltrials_resource:dbd41868ee618d3e64daa1adf8c3a8a0]

source [clinicaltrials_vocabulary:source]

Nobelpharma [clinicaltrials_resource:8ea02eeadbb7a673832c513c32215b7c]

start date [clinicaltrials_vocabulary:start-date]

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

study design [clinicaltrials_vocabulary:study-design]

clinicaltrials:NCT01246791 study design [clinicaltrials_resource:ce1e53e1711afb1b29b4246b0ef8c97e]

study type [clinicaltrials_vocabulary:study-type]

Interventional [clinicaltrials_resource:843ac00ae5d0b7c7defb84fb42c2ce31]

url [clinicaltrials_vocabulary:url]

NCT01246791

verification date [clinicaltrials_vocabulary:verification-date]

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

identifier

clinicaltrials:NCT01246791

http://www.w3.org/2001/XMLSchema#string

title

Pharmacokinetics of NPC-01 After Single Oral Administration in Healthy Female Volunteers

@en

inDataset

clinicaltrials_resource:bio2rdf.dataset.clinicaltrials.R3

type

Clinical Study [clinicaltrials_vocabulary:Clinical-Study]

clinicaltrials resource [clinicaltrials_vocabulary:Resource]

label

Pharmacokinetics of NPC-01 Aft ...... s [clinicaltrials:NCT01246791]

@en